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Aim of the study: The aim of the study 
was to investigate whether there are 
differences in the various dimensions 
of the health locus of control between 
oncological and non-oncological pa-
tients and to determine whether there 
is a relationship between the level of 
health locus of control and the type, 
duration of disease and gender.
Material and methods: The study was 
conducted at the Department of He-
matology and the 1st Department of 
Cardiology of the University Hospital 
in Krakow. 204 patients were enrolled. 
Our own questionnaire developed for 
this purpose and the Multidimension-
al Health Locus of Control scale were 
used. The US normalization group and 
the Polish standardization groups of 
the chronically ill patients were used 
for comparative analysis.
Results: Analysis showed significant 
differences between women and men 
in the Internal control scale (p < 0.02). 
The respondents from both groups 
showed lower scores in the Internal lo-
cus of control and much higher scores 
in the dimension Powerful Others. 
In the group of oncological patients, 
a  negative correlation was found be-
tween the Internal scale of health lo-
cus of control and the duration of the 
disease (p = 0.007). There was a signif-
icant difference between oncological 
and non-oncological patients in the 
Powerful Others scale (p < 0.004).
Conclusions: The results suggest that 
oncologically ill patients could be 
more convinced that others are re-
sponsible for their health when com-
pared to non-oncological patients. 
The longer the disease persists in on-
cological patients, the weaker is their 
internal motivation to achieve good 
treatment results.
Key words: cancer patients, chronic 
disorders, health locus of control, psy-
cho-oncology.
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Introduction
The locus of control (LOC) is an important feature that regulates the func-
tioning of people in a difficult situation, such as chronic illness. The concept 
of LOC derives from the theory of social learning by Rotter [1] and concerns 
beliefs about the source of health control [1, 2]. Less than 20 years after 
the release of Rotter’s “Social learning and clinical psychology”, Lavenson 
slightly modified and developed further this theory [3]. Finally, two types of 
LOC were distinguished in relation to the health condition: the internal LOC, 
which is an expression of the individual’s conviction about its direct impact 
on health, and external – when the person is convinced that their health 
condition depends on external factors. These may include luck, chance, 
fate, or the influence of other people [2–5]. People with an internal LOC are 
characterized by greater self-activity; they control their lives and important 
events themselves. They believe that the probability of success depends on 
their own efforts, work and personal influence. They stand out with their 
high aspirations and faith in their own strengths. Individuals with an ex-
ternal LOC believe that their lives are controlled by factors independent of 
their conscious, intentional and deliberate influence, such as fate, destiny, 
God, ignorance, disease, happiness, etc. In the face of illness, they submit to 
medical institutions and health care workers. They do not trust themselves 
and do not believe in the effectiveness of their own actions [5, 6].
Wortman and Dunkel-Schetter suggest that chronically ill patients who 
have an internal LOC may feel frustrated and helpless due to the inability to 
make a significant change in their health. On the other hand, people with an 
external LOC may be in a better mental condition because they do not try 
to control their environment and therefore do not experience a high level of 
frustration [7]. There are studies that indicate that the health locus of control 
(HLC) is linked to chronic diseases [8–11].
Cancer is a chronic and often incurable disease that patients have little 
control over. Moreover, many patients receive chemotherapy and/or radio-
therapy, which may cause a number of adverse reactions [12]. People strug-
gling with chronic illness, in the face of long-term treatment, may perceive 
their health differently.
The results of Polish research on the HLC in chronically ill patients indicate 
significant differences in the results compared to the American standardiza-
tion group in all dimensions of the HLC. Polish patients with chronic illnesses 
are characterized by higher scores in all dimensions of the Multidimension-
al Health Locus of Control (MHLC) scales [13, 14]; however no studies have 
been performed comparing the HLC in patients with cancer and in patients 
with other chronic diseases.
The aim of the study was to determine whether chronically ill patients 
not suffering from oncological disease differ from patients with chronic on-
cological disorder in individual dimensions of the MHLC, whether there is 
a relationship between the level of the HLC and gender, and whether the du-
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ration of the disease plays a significant role in the results 
obtained in both investigated groups of patients. 
Material and methods
As an example of chronic oncological disease 103 pa-
tients applying to the Outpatient Hematology Department 
of the University Hospital in Krakow suffering from leuke-
mia, lymphoma or multiple myeloma were enrolled in the 
study. The second group consisted of 101 patients with 
chronic cardiovascular diseases treated on an outpatient 
basis at the 1st Department of Cardiology, Interventional 
Electrocardiology and Arterial Hypertension. The study was 
carried out in the period from 11.2017 to 01.2018. All investi-
gated patients agreed to participate in the study and signed 
an informed consent form. The inclusion criteria for the on-
cological and non-oncological group were as follows: treat-
ment due to oncological disease or cardiovascular disease 
for a minimum of 6 months, age over 18 years and good 
general condition assessed according to the Eastern Coop-
erative Oncology Group performance scale (ECOG 1 or 2).
Research tools included: a questionnaire developed for 
the needs of the survey and the MHLC scale questionnaire 
in version B by Kenneth A. Wallston, Barbara S. Wallston, 
Robert DeVellis, in the adaptation of Zygfryd Juczynski.
Our own developed questionnaire included:
•	 sociodemographic questions about age, education and 
place of residence,
•	 questions related to the disease and treatment; name of 
the disease, other comorbidities; duration of treatment.
The MHLC scale questionnaire – contains 18 statements 
regarding general expectations in three dimensions of the 
HLC: Internal (W), Powerful Others (I) and Chance (P). All 
statements are presented on a six-point scale and include 
possible answers with the score: no, I  strongly disagree 
– 1 point, to some extent I disagree – 2 points, to a small 
degree I  disagree – 3 points, to a  small extent I  agree – 
4 points, to some extent I agree – 5 points, yes, I definitely 
agree – 6 points. The range of results is from 6 to 36 points. 
A higher score means a stronger belief about the influence 
of a given factor on health [15]. 
The American standards and our own norms for chron-
ically ill patients were used to compare the results. Our 
norms were created based on Polish standards [15]. 
The data were prepared using the IBM SPSS Statistics 
statistical program in version 24. Descriptive statistics 
(arithmetic mean [M] and standard deviation [SD]) were 
used, linear regression analysis and parametric tests: Stu-
dent’s t-test and Pearson’s correlation (r), which was used 
in the analysis of the relationship between the duration 
of disease and the level of HLC. The level of significance 
was p < 0.05. Verification of normality of the distribution 
was performed by the Kolmogorov-Smirnov test, where 
the distribution was considered as “normal” at p > 0.05.
Results
The analysis included 204 questionnaires, filled in by 101 
patients suffering from oncological disease and 103 non-on-
cological patients. The mean age of the respondents in the 
oncology group was 58.8 ±13.44 years and 55.44 ±13.55 
years in the group of the remaining patients. The average 
duration of oncological illness was 7 years and 5 months 
±3.57 years, and of non-oncological chronic disease was 
13 years and 6 months ±9.7 years. The types and incidences 
of chronic diseases in both groups are presented in Table 1.
In the group of oncological patients (n = 103), in 16 pa-
tients (15.53%), apart from oncological disease, one of 
the above-mentioned chronic diseases was present, in 
9 people (8.74%) two other chronic diseases occurred, 
and in 6 patients (5, 83%), the three diseases mentioned 
above. In the non-oncological group of patients (n = 101), 
48 (47.52%) suffered from the two diseases listed above, 
22 patients (21.78%) from 3 diseases and 6 people (5.94%) 
from four.
Comparative results of the MHLC scale revealed a statisti-
cally significant difference between the groups in the dimen-
sion Powerful Others (t = 2.91, p < 0.004). The respondents 
Table 1. Types and incidences of chronic diseases in the studied 
groups* (N = 204)
Illness Occurrence
n (%)
Duration (in years)
M            SD
Hypertension 84 (41.2) 12.57 7.208
Oncological disease 103 (51.5) 7.45 3.574
Thyroid disease 20 (9.8) 10.95 5.846
Heart disease  32 (15.7) 11.78 6.657
Eye disease 10 (4.9) 16.30 10.152
Diabetes 15 (7.4) 13.07 6.312
Disease of bones  
or vertebral spine
24 (11.76) 19.88 7.891
Other 19 (9.31) 8.89 3.879
M – mean, SD – standard deviation, * in both groups, the patients mentioned 
a few chronic diseases in the survey
Table 2. Comparison of the average results of the Multidimensional 
Health Locus of Control scale obtained by the surveyed groups
Health locus 
of control
Oncological 
patients
n = 103
M ±SD
Non-oncological 
patients
n = 101
M ±SD
t p-value
Internal 24.92 ±5.61 24.61 ±4.96 0.416 0.678
Powerful 
Others
28.59 ±4.76 26.38 ±6.05 2.909** 0.004
Chance 22.92 ±5.67 21.71 ±5.57 1.535 0.126
M – mean, SD – standard deviation, t – Student’s t-test result, * p < 0.05,  
** p < 0.01
Table 3. Average normalization indices of the health locus of control 
in chronically ill patients – American standards [19] and our own 
norms
Health locus  
of control
American standards
n = 609*
M 
Own norms 
n = 101**
M
Internal 25.78 24.95
Powerful Others 22.54 25.36
Chance 17.64 21.22
M – mean, * source: Wallston 1981, ** standards created for the needs of this 
study
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from both groups obtained lower scores in the dimension of 
the Internal LOC and much higher scores in the dimensions 
Powerful Others and Chance (Table 2) in comparison to the 
American standardization group (Table 3).
Table 3 presents American standards published in the 
book Measuring Tools in Promotion and Psychology of Health 
and our own norms created for the needs of this study.
In the group of oncological patients, the analysis 
showed a negative correlation between the Internal di-
mension of HLC and the duration of the disease (r = –0.265, 
p = 0.007). In the group of non-oncologically ill patients, 
a positive correlation between the duration of disease 
and the dimension Powerful Others was found (r = 0.239, 
p = 0.016). The results are presented in Table 4.
Tables 4a and 4b show a linear regression analysis – influ-
ence of variables: sex, age, duration of disease, place of res-
idence, occurrence (or not) of oncological disease on depen-
dent variables – individual MHLC factors.
The analysis showed a significant impact of the gender vari-
able on the level of the Internal LOC (p = 0.038). Women, com-
pared to men, have a lower Internal LOC by 1.6 points. The re-
sult has been standardized into variables entered in the model.
The analysis showed a significant effect of age on the level 
of the variable Powerful Others (p = 0.025). A year older people 
achieved about 0.065 more points on this scale. The analysis 
also showed the influence of the oncological and non-on-
cological disease variable on the results of Powerful Others 
(p = 0.001). Non-oncologically ill patients have a 2.7 points low-
er level of the LOC in the factor Powerful Others. The result was 
standardized for the remaining variables. 
No statistically significant differences were found in the 
model for the Chance variable.
Differences in individual parameters of the HLC be-
tween women and men in all patients are listed in Table 2. 
A joint analysis of patients from both groups indicates sta-
tistically significant differences between women and men 
in Internal control – internal LOC (t = 2.29, p < 0.02). In 
Table 4. Pearson’s correlation coefficient (r) between the MHLC 
scale dimensions and the duration of the disease
Health locus 
of control
Oncological patients
n = 103
        r            p-value
Non-oncological patients
n = 101
     r                p-value
Internal –0.265** 0.007 0.043 0.667
Powerful Others 0.001 0.990 0.239* 0.016
Chance 0.013 0.900 0.145 0.147
Table 4a. Variable – Internal locus of the control
Predictors Unstandardized 
coefficients
    B        Std. error
Standardized 
coefficients
β
      t       p-value
Constant 28.110 1.880 0.000
Oncological/
Non-
oncological ill
0.009 0.763 0.001 0.012 0.990
Age –0.037 0.028 –0.093 –1.301 0.195
Duration  
of disease
–0.050 0.044 –0.084 –1.140 0.255
Sex –1.559 0.745 –0.148 –2.091* 0.038
Table 4b. Variable – Powerful Others
Predictors Unstandardized 
coefficients
    B     Std. error
Standardized 
coefficients
β
t p-value
(Constant) 27.247 1.967 0.000
Oncological/
Non-
oncologically ill
–2.658 0.785 –0.241 –3.388** 0.001
Age 0.065 0.029 0.158 2.265* 0.025
Duration  
of disease
0.078 0.045 0.126 1.753 0.081
Sex –0.952 0.775 –0.086 –1.229 0.221
Place  
of residence
0.427 0.823 0.036 0.519 0.604
Table 5. Health locus of control in all respondents in relation to gen-
der (Student’s t-test)
Health locus  
of control
Both groups together
Women
n = 106
M ±SD
Men
n = 98
M ±SD
t p-value
Internal 23.96 ±5.56 25.64 ±4.86 2.291* 0.023
Powerful 
Others
27.14 ±5.72 27.88 ±5.34 0.948 0.344
Chance 23.04 ±5.96 21.55 ±5.21 –1.892 0.060
M – mean; SD – standard deviation; t – Student’s t-test result, * p < 0.05, 
** p < 0.01
Table 5a. Health locus of control in relation to gender in the group of 
non-oncological patients (Student’s t-test)
Health locus 
of control
Non-oncological patients
Women
n = 106
M ±SD
Men
n = 98
M ±SD
t p-value
Internal 23.85 ±4.90 25.49 ±4.93 1.670 0.098
Powerful 
Others
25.39 ±6.45 27.51 ±5.40 1.777 0.079
Chance 21.67 ±6.08 21.77 ±4.99 0.089 0.928
Table 5b. Health locus of control in relation to gender in the group of 
oncological patients (Student’s t-test)
Health locus 
of control
Oncological patients
Women
n = 52
M ±SD
Men
n = 51
M ±SD
t p-value
Internal 24.08 ±6.22 25.78 ±4.83 1.554 0.123
Powerful 
Others
28.96 ±4.18 28.22 ±5.41 –0.793 0.430
Chance 24.46 ±5.53 21.35 ±5.44 –2.876** 0.005
M – mean, SD – standard deviation, t – Student’s t-test result, * p < 0.05,  
** p < 0.01
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other dimensions, no statistically significant differences 
were found between men and women.
Tables 5a and 5b presents differences in the HLC ac-
cording to gender separately for both investigated groups 
of patients. In the group of oncological patients there were 
statistically significant differences in the external HLC lo-
cated in the Chance scale (t = –2.88, p < 0.004) in relation 
to gender (Table 5b). Statistically significant differences 
occurred between oncological and non-oncological wom-
en in the Chance scale (t = 2.47, p < 0.015) and Powerful 
Others (t = 3.37, p < 0.001). The separate analysis of both 
groups did not show a significant difference in men in the 
factor Internal LOC. No statistically significant differences 
were found in the other factors.
Discussion
The aim of the study was to determine and to compare 
the HLC among oncological and non-oncological patients 
and to understand differences between the groups. For the 
comparison of the internal and external HLC, a confirmed 
MHLC scale was used in both groups. The MHLC scale has 
been used for several years in many studies concerning 
oncological patients [13, 16, 17] and chronically ill patients 
without cancer [14, 18]. The HLC is an important factor in 
determining how the patient deals with the disease, treat-
ment and rehabilitation.
The standards for the investigations of chronically ill 
patients in the USA were created on the basis of studies 
carried out in the years 1978–1979 [19]. Therefore it was 
decided to compare the results of the present research 
with the average results of the American standardization 
group and additionally with our own norms based on Pol-
ish research carried out in the years 1998–1999 by Juczyn- 
ski, performed on several groups of patients representing 
various disease entities [15]. Juczynski published Polish 
standards for the MHLC tool in his book “Measuring Tools 
in Promotion and Psychology of Health” [15]. These norms 
were established for several different chronically ill patient 
groups: undergoing dialysis, diabetics patients, men after 
myocardial infarction, women with complicated pregnan-
cy, women during menopause, and women after mastec-
tomy. Of all of these groups, only the dialysis (n = 31) and 
diabetics (n = 70) patients were included in our own norms 
of chronically ill patients. The other groups were rejected 
because they presented norms only for one of the sexes. 
From the obtained results of the two groups, the average 
for each of the dimensions was calculated.
Studies that assessed separately the HLC in oncolog-
ically and chronically non-oncologically ill patients could 
be found in available literature; however, there is a lack of 
studies presenting a direct comparison of both groups.
The literature on research on the HLC indicates the 
internal LOC as a factor facilitating the actions taken to 
prevent health problems and avoiding health-threatening 
behaviors [17]. It is believed that people with a higher level 
of Internal LOC may be in better health than people who, 
in the assessment of this factor, achieve a lower level [20]. 
In the present study, it was found that patients with chron-
ic diseases in both groups obtained lower results (oncolog-
ical – M = 24.92, SD = 5.61, non-oncological – M = 24.61, 
SD = 4.96) on the Internal LOC scale in comparison to the 
American standardization group (M = 25.78) and compara-
ble to our own created norms (M = 24.95). With regard to 
American norms [15], chronically ill patients from our study 
group had a lower level of Internal LOC. They may think 
that they have little influence on their own life and health 
situation, may not undertake pro-health activities, and not 
seek to improve health to the same extent as people with 
a higher level of Internal LOC. The results obtained in this 
study may suggest that when compared to our own norms 
the patients believe that they have a moderate impact on 
their own health situation, and they approach them with 
detachment from pro-health activities.
The present results are different from the results of Kur-
pas et al. [14] and from some of the results of Kosowicz 
et al. [13]. In the research of Kurpas, the HLC factors were 
examined in people with chronic disorders, including those 
with chronic cardiovascular and nervous system diseases 
and with diabetes. The subject of Kosowicz’s research was 
“The health locus of control, anxiety and depression in pa-
tients with soft tissue and bone cancer”, in which the pa-
tients treated for the first time and once again were sub-
jected to the tests. In the reported studies, patients with 
chronic illness (Kurpas) and cancer patients (Kosowicz) 
had higher scores on the Internal LOC scale compared to 
both groups of oncological and non-oncological patients in 
our study, except for patients with nervous system diseas-
es [14] and patients with cancer treated for the first time 
[13], where the results were significantly lower (M = 23.50, 
SD = 5.78). It is worth noting that in the studies of Koso-
wicz, the studied group of patients consisted of 40 cancer 
patients, including 22 patients treated for the first time 
and 18 patients treated once more, and in the present 
study a total of 204 patients were examined, including 
103 oncologically ill patients, which could at least partially 
explain the differences in the obtained results. Another dif-
ferentiating factor may be the duration of the disease and 
the phase of treatment in which they are. Patients treated 
for cancer for the first time have a much weaker belief that 
they can decide about their health condition themselves, 
they do not know what to expect and they are burdened 
with enormous stress. The patient who receives the sec-
ond cycle of treatment is already richer with this knowl-
edge and experience from the first stage of treatment [21]. 
The type of cancer, the method of treatment and inclusion 
of a group of people with cancer recurrence could probably 
also influence the variety of results. 
Patients with high scores on the Internal LOC scale ex-
hibit the most pro-healthy behaviors compared to other 
patients. In the present study, both groups were character-
ized by slightly lower results on this scale and much high-
er on the other scales when compared to our own norms. 
Such results may suggest that the patients from the stud-
ied group are weekly motivated to fight the disease by 
themselves, their actions are characterized by significant 
passivity and they place faith in external actions that are 
to lead to cure. Their rehabilitation and therapy process 
may be significantly longer than those with different re-
sults and more disruptive for themselves.
The regression analysis showed that women compared to 
men have a lower Internal LOC by 1.6 points (p = 0.038). How-
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ever, the comparison of the results of this variable in both 
groups separately showed a significant difference only in the 
Chance factor. In the oncological group, women had signifi-
cantly higher scores than men. Sherman and others analyzed 
a lot of research on differences in individual LOC parameters 
in women and men, where different variables, such as men-
tal health condition, social efficacy or stress, are also affected 
by the results on individual scales [22]. Therefore, in order to 
better refer to the obtained results, not only gender but also 
other factors should be taken into account in future studies. 
Research by Burish et al. suggested that the exter-
nal LOC may be beneficial in helping cancer patients to 
adapt to their chronic disease [23]. Patients in both groups 
showed much higher scores on the Powerful Others scale 
compared to the American normalization group (M = 
22.54) and slightly higher when compared to their own 
normalization group (M = 25.36). The study also revealed 
a significant difference between the two groups (t = 2.909, 
p < 0.01) in this dimension (Table 4). The group of onco-
logical patients obtained similar results to the group of 
patients with diabetes (M = 28.08, SD = 6.46) in the study 
of Kurpas [14] and to the group of patients with cancer 
treated once again (M = 28.11, SD = 5.17) in the study of 
Kosowicz [13]. Similarly, in other studies oncological pa-
tients had higher scores on the scale of the external LOC 
compared to the control group of healthy people [24, 25]. 
According to Levenson, patients with high scores on the 
Powerful Others scale may have more problems with effec-
tive coping with illness and react negatively to rehabilitation 
[26]. These patients may be convinced that others, for ex-
ample health care workers, are responsible for their health, 
the therapy process and rehabilitation. This can reduce the 
consistency of complying with medical advice, including fol-
lowing prescriptions, and can negatively affect the regular-
ity or examinations as well as doctor’s appointments [27].
The analysis performed in our studied group showed 
that non-oncological patients in comparison to oncolog-
ical patients have 2.7 points lower level of control in the 
discussed factor. These results seem to confirm the obser-
vation made by Levenson. Wallston and Wallston also sug-
gested that in situations where only low internal control 
is possible, as in patients with cancer, patients are depen-
dent more on external sources of control, such as doctors 
or others (e.g. family), than on internal ones [28].
There were no significant differences between oncolog-
ical and non-oncological groups in the Chance factor. Pa-
tients with an elevated score on this scale may believe that 
their lives and health are determined by their fate or chance 
[29]. In both studied groups the sores were higher (onco-
logical: M = 22.92, non-oncological: M = 21.71) than in the 
American normalization group (M = 17.64) and comparable 
to our own norms (M = 21.22). In the studies of Kosowicz 
[13] and Kurpas [14] in all the studied groups, much higher 
results were obtained when compared to both normaliza-
tion groups (own group and an American group) and slightly 
higher compared to those obtained in the present study. 
The study showed that in the group of oncological pa-
tients, the longer the duration of the disease was, the low-
er are the obtained results in terms of the Internal LOC 
(r = –0.265, p = 0.007). This could suggest that the longer the 
respondents get sick, the weaker is their internal motivation 
and the belief that they contribute to achievement of good 
treatment results. Their sense of responsibility for the treat-
ment process could be decreased, and they are not willing 
to take pro-health measures. As the other research results 
show, the duration of the disease may affect the mental 
condition of patients; the longer the chronic illness lasts, 
the worse are the quality of life and the mental condition 
[30]. In the group of patients with non-oncological chron-
ic disease, prolonged duration of the disease correlated 
with higher results obtained in Powerful Others (r = 0.239, 
p = 0.016). This suggests that the longer patients get sick, 
the more they perceive their own health as a result of other 
“external” activities, such as health care and medical per-
sonnel. With the duration of the disease, the deteriorating 
mental condition of patients may cause patients to trust 
others more in the treatment process. It was suspected that 
in each of the groups the duration of the disease would cor-
relate with all of the above dimensions; however, the cor-
relations appeared only in one of the three expected factors. 
It should be taken into account that the above analyses 
on the MHLC scale and other Polish studies mentioned 
above were compared with the normalization group of 
patients chronically ill from the USA [15]. People who are 
healing and suffering in another country may differ in many 
respects: cultural, social, property and other. The healthcare 
system, and access to medicines and specialists are com-
pletely different in the United States than in Poland. There is 
a lack of reliable standardization group of patients suffering 
from chronic illnesses described in the Polish literature. 
Therefore a clinical investigation aiming at develop-
ment of a reliable Polish standardization group of chron-
ically ill patients should be planned.
The standards for the investigations of chronically ill pa-
tients in the USA were created on the basis of studies car-
ried out in the years 1978–1979 [19]. Therefore it was decid-
ed to compare the results of the present research with the 
average results of the American standardization group and 
additionally with our own norms based on Polish research 
carried out in the years 1998–1999 by Zygfryd Juczynski, per-
formed on several groups of patients representing various 
disease entities [15]. Juczynski published Polish standards 
for the MHLC tool in his book “Measuring Tools in Promo-
tion and Psychology of Health” [15]. These norms have 
been established for several different chronically ill patient 
groups: undergoing dialysis, diabetics patients, men after 
myocardial infarction, women with complicated pregnancy, 
women during menopause, and women after mastectomy. 
Of all of these groups, only the dialysis (n = 31) and diabetics 
(n = 70) patients were included in our own norms of chron-
ically ill patients. The other groups were rejected because 
they presented norms only for one of the sexes. From the 
obtained results of the two groups, the average for each of 
the dimensions was calculated.
There are many interpretations in the literature of in-
dividual factors influencing the LOC and many questions 
regarding the validity of the MHLC scale have been raised 
[31, 32]. The relationship between individual dimensions 
and health outcomes is very complicated as described 
in the literature review published in 2007 [33]. Given the 
above, one should be cautious about the conclusions of 
the studies in which the MHLC scale is used. Therefore fu-
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ture investigations should incorporate and analyze a wide 
range of variables in addition to MHLC to elucidate fur-
ther and describe more precisely the relations between 
patient-related individual factors of the HLC.
Conclusions
The current study may suggest that oncologically ill patients 
could be more convinced that others are responsible for their 
health compared to non-oncological patients.
Oncologically ill men believe more in their own strength 
than women from the same group. Women show stronger be-
lief than men about the impact of the accident on their health.
The results may suggest that the longer the disease persists 
in oncological patients, the weaker is their internal motivation 
to achieve results in treatment, and their sense of responsi-
bility for the process weakens. In the case of non-oncological 
patients, the longer they get sick, the more they perceive their 
own health as a result of the actions of other people.
Both groups tested showed higher scores at all scales in com-
parison with the American standardization group and compara-
ble to our own standardization group created for this study.
To properly compare each of the dimensions of the MHLC 
scale for chronically ill patients, it would be recommended to 
create a large Polish standardization group.
The authors declare no conflict of interest.
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